VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

SEC Filing Details

Document Details

Form
Filing Date
Apr 24, 2019
Document Date
Apr 23, 2019
Form Description
Initial filing by director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Vanda Pharmaceuticals Inc.
Issuer
Vanda Pharmaceuticals Inc.
Filer
Chrousos Phaedra
Copyright © 2005-2024 Vanda Pharmaceuticals Inc. |